Skip Navigation

BlissCo's International Cannabis Ecosystem Taking Shape -- CFN Media

SEATTLE, WA - (NewMediaWire) - June 28, 2018 - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering BlissCo Cannabis Corp. (CSE:BLIS) (CNSX:BLIS) (BLIS.CN), a Canadian licensed producer of legal cannabis, and a company that subscribes to the old maxim, “From humble beginnings come great things.” Considering recent company developments, BlissCo appears to be much closer to the ‘great things’ end of the saying than to the ‘humble beginnings’ phase. The company is quickly moving forward with its plan to develop a complete ecosystem of cannabis product development, focusing on branding and packaged goods for both the Canadian market and for the emerging global industry.

Advancing the Licensing Process

BlissCo received its cultivation license under the Health Canada ACMPR program on March 29, 2018, and started cultivation within a month. Not content to wait, with full legalization scheduled for this fall, the company took advantage of its supply agreement with The Supreme Cannabis Company to jumpstart the application process for its sales license. BlissCo accepted the first shipment from the two-year, 3,000 kg agreement so it could properly package and process the flower for its application to sell dried cannabis. The company plans to complete that application in July and is hopeful of award in September, ahead of the scheduled October 17 legalization date.

Meanwhile, BlissCo submitted its application for a cannabis oil production license on June 6. The oil license is a crucial piece in the company’s strategy, as it has designed its Vancouver-area facility to be a medical-grade, high volume production, packaging, and distribution center for cannabis-derived products. BlissCo anticipates producing 420 kg annually from Phase 1, with an expansion to follow. The company intends to create both medical and recreational products, utilizing an advanced extraction system to create full spectrum oils that maintain the extensive terpene and component profiles of the original plants.

International and Alternative Markets

With Canada’s licensed producers providing much of the supply due to the maturity of its regulated market, the emerging world export market is estimated at around $200 billion dollars. That number will likely grow in the coming years as more countries recognize the benefits of cannabis as medicine. An impressive list of countries have recently developed medical programs, including Australia, Peru, Mexico, Germany, Greece, Italy, and Poland. It’s a trend that is turning into a wave, and BlissCo intends to ride it.

Upon the anticipated receipt of its sales license, the company intends to apply for export permits to a variety of countries. In preparation, and as an example of the company’s strategy, BlissCo announced a letter of intent with a German company to sell and distribute 720 kg of flower product in Germany. The German market is the most mature in Europe and has the greatest potential at this point due to the size of the population and the fact that the government provides insurance coverage for medical cannabis. Demand is expected to far outstrip domestic German supply over the next few years, making it an even more enticing market for the company. In another nod to the German market, BlissCo is co-listed on the Frankfurt stock exchange, an emerging source of capital and investor interest for public cannabis companies.

The company is also looking to enter the alternative and complementary medicine market. Development of natural medicines derived from cannabis, medicines that don’t require elaborate and expensive clinical trials, will give BlissCo access to another lucrative market that is estimated to reach nearly $200 billion globally in the coming years. It’s a natural fit for the company’s overall strategy of building a complete ecosystem of cannabis-related products. Still, the company plans to pursue the clinical trial model as well, recognizing the value that scientific validation and drug approvals can return for the company.

The BlissCo Ecosystem

From its humble beginnings in 2013, BlissCo has patiently built the foundation and is executing on the construction of the great things envisioned by the company. Maintaining its small company approach has allowed BlissCo to nimbly adapt to the ever-changing industry, and developments are coming fast and furious over the last few months. By leveraging key partnerships and licenses, the company continues to build the ecosystem of a small organization with big global aspirations.

Please follow the link to read the full article: http://www.cannabisfn.com/blisscos-international-cannabis-ecosystem-taking-shape/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com